Sec Form 4 Filing - GOULD MARTIN @ AMERICAN BIO MEDICA CORP - 2009-11-22

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
GOULD MARTIN
2. Issuer Name and Ticker or Trading Symbol
AMERICAN BIO MEDICA CORP [ ABMC]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
EVP & CSO
(Last) (First) (Middle)
C/O ABMC ATTN: MELISSA WATERHOUSE, 122 SMITH ROAD
3. Date of Earliest Transaction (MM/DD/YY)
11/22/2009
(Street)
KINDERHOOK, NY12106
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Statutory Stock Option $ 2.5 11/22/2009( 1 ) J( 2 ) 100,000 06/30/2000( 3 ) 11/22/2009 Common Shares 100,000 ( 4 ) 260,000 ( 5 ) D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
GOULD MARTIN
C/O ABMC ATTN: MELISSA WATERHOUSE
122 SMITH ROAD
KINDERHOOK, NY12106
EVP & CSO
Signatures
Martin R. Gould 12/09/2009
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Option grant was originally issued on 11/22/99 and reported on a Form 3 filed in 2003. The expiration date of 11/22/09 was reported on this filing.
( 2 )Option grant expired naturally on 11/22/09.
( 3 )When option grant was initially issued it vested over 4 years with first 25% vesting on 6/30/2000.
( 4 )The closing price of the Company's common shares on the date of the grant (11/22/99) was $1.63. The closing price of the Company's common shares on 11/23/09 (the trading day immediately following the expiration date of 11/22/09) was $0.14.
( 5 )Mr. Gould currently has 5 option grants covering a total of 260,000 common shares of the Company. Each of these 5 grants has been previously reported on the appropriate Section 16(a) filing.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.